The Worldwide Recombinant Proteins Industry is Expected to Reach $8.6 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Recombinant Proteins Market Research Report by Product, Application, End User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Recombinant Proteins Market size was estimated at USD 3,892.78 million in 2021, USD 4,436.22 million in 2022, and is projected to grow at a CAGR 14.21% to reach USD 8,641.69 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Recombinant Proteins Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Recombinant Proteins Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Recombinant Proteins Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Recombinant Proteins Market?

4. What is the competitive strategic window for opportunities in the Global Recombinant Proteins Market?

5. What are the technology trends and regulatory frameworks in the Global Recombinant Proteins Market?

6. What is the market share of the leading vendors in the Global Recombinant Proteins Market?

7. What modes and strategic moves are considered suitable for entering the Global Recombinant Proteins Market?

Market Dynamics

Drivers

• Rising Focus on Personalized Medicine & Protein Therapeutics in the Consumers
• High Prevalence of Infectious & Chronic Diseases Among Geriatric Population and Children
• Surging Inclination of Demand Toward Biologics and Biosimilars Proteins

Restraints

• Declining Cost of Recombinant Proteins and Availability of Alternative Products

Opportunities

• Increasing Focus on Biomarker Discovery and Surging Rise of New Ingredients
• Rising Investments and New Product Development in the Recombinant Protein Market
• Growing Demand for Recombinant Protein in Animal Production

Challenges

• Concerns Regarding Time Consumption Coupled with High Costs and Maintenance of Recombinant Protein

Companies Mentioned

• Abcam plc
• Abnova Corporation
• ACROBiosystems
• Bio-Rad Laboratories, Inc.
• BioLegend, Inc.
• BPS Bioscience, Inc.
• CellGenix GmbH
• Enzo Life Sciences, Inc.
• GenScript Biotech Corporation
• Merck KGaA
• Miltenyi Biotech Inc.
• Neuromics
• PeproTech, Inc.
• ProSpec-TechnoGene Ltd.
• Proteintech Group, Inc.
• R&D Systems, Inc.
• RayBiotech Inc
• Sino Biological Inc.
• STEMCELL Technologies Inc.
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/6catqx

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900